Molecular docking, MM/GBSA and 3D-QSAR studies on EGFR inhibitors (original) (raw)

Computational Studies of Epidermal Growth Factor Receptor: Docking Reliability, Three-Dimensional Quantitative Structure−Activity Relationship Analysis, and Virtual Screening Studies

Stefania Sartini

Journal of Medicinal Chemistry, 2009

View PDFchevron_right

Computational Studies of Epidermal Growth Factor Receptor: Docking Reliability, Three-Dimensional Quantitative Structure− Activity Relationship Analysis, and …

Tiziano Tuccinardi

Journal of medicinal …, 2009

View PDFchevron_right

Design of EGFR kinase inhibitors: A ligand-based approach and its confirmation with structure-based studies

Gopalakrishnan Bulusu

Bioorganic & medicinal …, 2003

View PDFchevron_right

Structural identification of novel pyrimidine derivatives as epidermal growth factor receptor inhibitors using 3D QSAR, molecular docking, and MMGBSA analysis: a rational approach in anticancer drug design

sushil kashaw

Mediterranean Journal of Chemistry

View PDFchevron_right

Ligand based 3D-QSAR approach of EGFR

Rajeswari Jinka

View PDFchevron_right

Pharmacophore modeling, 3D-QSAR, docking and ADME prediction of quinazoline based EGFR inhibitors

Mohemmed Faraz Khan

Arabian Journal of Chemistry, 2016

View PDFchevron_right

Design, 3D QSAR modeling and docking of TGF-β type I inhibitors to target cancer

S. Kabilan

Computational biology and chemistry, 2018

View PDFchevron_right

Design of New Quinazoline Derivative as EGFR (Epidermal Growth Factor Receptor) Inhibitor through Molecular Docking and Dynamics Simulation

herlina rasyid

Indonesian Journal of Chemistry, 2020

View PDFchevron_right

QSAR and Molecular Docking of Phthalazine Derivatives as Epidermal Growth Factor Receptor (EGFR) Inhibitors

vithal kulkarni

Journal of Applied Pharmaceutical Science, 2017

View PDFchevron_right

3D-QSAR, molecular docking, and dynamics simulation of quinazoline–phosphoramidate mustard conjugates as EGFR inhibitor

resky amelia

Journal of Applied Pharmaceutical Science, 2019

View PDFchevron_right

Molecular docking, pharmacophore modeling and 3D-QSAR approach on a series of piperidone derivatives as potential anticancer agents by targeting the enzyme VEGFR-2 tyrosine kinase

nitesh sahu

View PDFchevron_right

Design of novel pyrazolyl-thiazolinone derivatives as a potential EGFR and HER-2 kinase inhibitors by 2D and 3D QSAR using kNN MFA and molecular docking method

Amruta Nikam

Journal of Current Pharma Research

View PDFchevron_right

Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors

Sako Mirzaie

View PDFchevron_right

3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors

BIBHUTI KAKOTI

Journal of Theoretical Biology, 2016

View PDFchevron_right

Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods

Mahboubeh Mansourian

Research in Pharmaceutical Sciences

View PDFchevron_right

Towards predictive inhibitor design for the EGFR autophosphorylation activity

Amor San Juan

2008

View PDFchevron_right

Molecular modeling studies of quinoline derivatives as VEGFR-2 tyrosine kinase inhibitors using pharmacophore based 3D QSAR and docking approach

alireza azizi

View PDFchevron_right

A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rational approach to anticancer drug design

Malleshappa Noolvi

Journal of Saudi Chemical Society, 2013

View PDFchevron_right

Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies

Seema Zargar

Biomolecules, 2022

View PDFchevron_right

Discovery of novel EGFR tyrosine kinase inhibitors by structure-based virtual screening

Xianqiang Sun

Bioorganic & medicinal chemistry …, 2012

View PDFchevron_right

Receptor-Based Virtual Screening of EGFR Kinase Inhibitors from the NCI Diversity Database

Napat Songtawee

Molecules, 2010

View PDFchevron_right

Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations

Camila Muñoz

Journal of Molecular Graphics & Modelling

View PDFchevron_right

Pharmacophore modeling, 3D-QSAR, docking and ADME prediction of quinazoline based EGFR inhibitors Production and hosting by Elsevier

Mohemmed Faraz Khan

View PDFchevron_right

Docking and molecular dynamics studies of new potential inhibitors of the human epidermal receptor 2

Rafael Feital

Molecular Simulation, 2012

View PDFchevron_right

Implication of molecular docking in the study of structure-activity relationship of receptor tyrosine kinases inhibitors

Baratali Mashkani

2011

View PDFchevron_right